Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Precision System Science Co's enterprise value is 円5,618 Mil.
Precision System Science Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円579 Mil. Therefore, Precision System Science Co's EV-to-EBITDA for today is 9.70.
The historical rank and industry rank for Precision System Science Co's EV-to-EBITDA or its related term are showing as below:
TSE:7707'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -6319.1 Med: -6.69 Max: 199.27
Current: 9.7
During the past 13 years, the highest EV-to-EBITDA of Precision System Science Co was 199.27. The lowest was -6319.10. And the median was -6.69.
TSE:7707's EV-to-EBITDA is ranked better than 67.12% of 520
companies
in the Medical Devices & Instruments industry
Industry Median: 14.68
vs TSE:7707: 9.70
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Precision System Science Co (TSE:7707) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Precision System Science Co's PE Ratio (TTM) for today is calculated as:
Precision System Science Co's share price for today is 円217.00.
Precision System Science Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円14.408.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7707 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Precision System Science Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Precision System Science Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Precision System Science Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Precision System Science Co's EV-to-EBITDA falls into.
Precision System Science Co's current Enterprise Value is 円5,618 Mil.
Precision System Science Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円579 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Precision System Science Co (TSE:7707) has a EV-to-EBITDA of 9.70 as of Aug. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Precision System Science Co. According to the industry distribution chart, Precision System Science Co ranks #171 out of 520 companies in the Medical Devices & Instruments industry, placing it in the top 32.9%.
Is Precision System Science Co's EV-to-EBITDA too high?
Precision System Science Co's current EV-to-EBITDA is 9.70. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.68. Precision System Science Co's value of 9.70 is 33.9% below this industry median. Based on the distribution chart, Precision System Science Co ranks #171 out of 520 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Precision System Science Co has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Precision System Science Co's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Precision System Science Co ranks #171 out of 520 companies for EV-to-EBITDA. This puts Precision System Science Co in the upper half of its industry. The industry median EV-to-EBITDA is 14.68. Precision System Science Co's value of 9.70 is 33.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.68, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Precision System Science Co's current EV-to-EBITDA of 9.70 is 33.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Precision System Science Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Precision System Science Co's current EV-to-EBITDA is 9.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precision System Science Co stock overvalued right now?
Based on GuruFocus' analysis, Precision System Science Co (TSE:7707) is currently considered Modestly Undervalued. The stock's GF Value™ is 円261.58, compared to a current price of 円217.00 — trading 17% below its estimated fair value. The current EV-to-EBITDA is 9.70 and 33.9% below the Medical Devices & Instruments industry median of 14.68. Precision System Science Co's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Precision System Science Co (TSE:7707), the current EV-to-EBITDA is 9.70 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Precision System Science Co (TSE:7707) Overvalued in 2026?
Based on GuruFocus' analysis, Precision System Science Co stock appears to be undervalued.
The current stock price of 円217.00 is trading 17% below its estimated GF Value™ of 円261.58.
GuruFocus considers Precision System Science Co to be Modestly Undervalued.
Key valuation signals for TSE:7707:
EV-to-EBITDA: 9.70
GF Value™: 円261.58 vs. price of 円217.00 (17% below fair value)
Industry Position: 33.9% below the Medical Devices & Instruments median (#171 of 520)
No single metric tells the full story. See the TSE:7707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Precision System Science Co Ltd is engaged in the development, manufacture, and sale of vitro diagnosis like genetic testing, protein inspection, automation equipment. The company is also engaged in production and sales of reagents and plastic consumables.
48GF Score
Get the complete analysis for TSE:7707
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7707 has been successfully added to your 
